What is Roth Capital’s Forecast for FBIO Q1 Earnings?
Fortress Biotech, Inc. (NASDAQ:FBIO – Free Report) – Roth Capital issued their Q1 2025 earnings estimates for Fortress Biotech in a research report issued on Tuesday, March 11th. Roth Capital analyst J. Wittes forecasts that the biopharmaceutical company will post earnings of $1.47 per share for the quarter. The consensus estimate for Fortress Biotech’s current […]
